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Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by mental
retardation, epilepsy and hamartomatous growth in many tissues.  The gene (TSC2)
encoding a tumor suppressor protein whose mutations cause TSC, has been demon-
strated to be expressed at high levels in the adult and developing brain, raising the
question of whether or not the TSC2 gene product has unique roles in differentiation
related to cytoskeletal interactions within the central nervous system, in addition to a
tumor suppressor function.  To determine the expression of TSC2 in functionally distinct
neuron types of the mouse brain, we carried out in situ hybridization with digoxigenin-
labeled riboprobes for the detection of TSC2 mRNA.  High levels of the TSC2 gene
were in neurons of the pyramidal and dentate granular layer in the hippocampus, cere-
bellar Purkinje cells, neurons of the piriform cortex, motor neurons in the medulla and
interneurons in the striatum, while intermediate levels were in cortical neurons, striatal
neurons, septal neurons, thalamic neurons and neurons in the substantia nigra compacta.
Thus, the high expression of the TSC2 gene has restricted distribution in specific neu-
ronal types which are characterized by well-developed dendrites and rich in use-
dependent long-term changes in synaptic efficacy.  These results suggest that the function
of the TSC2 gene product may be involved on a cellular basis in neuronal plasticity and
relevant to mental retardation observed in TSC patients.
Key words:  tuberous sclerosis gene; cytoskeletal interaction; neuronal plasticity; in situ hybrid-
ization; mouse brain
Abbreviations:  bp, base pair; cDNA, complementary DNA; dCTP, deoxy-CTP; DEPC, diethyl pyro-
carbonate; kb, kilobase; mRNA, messenger RNA; LTD, long-term depression; LTP, long-term potentiation;
NBT, nitroblue tetrazolium salt; RT-PCR, reverse transcription-coupled polymerase chain reaction; tRNA,
transfer RNA; TSC, tuberous sclerosis complex; TSC1, locus on chromosome 9q34.3 for TSC; TSC2, locus
on chromosome 16q13.3 for TSC
Tuberous sclerosis complex (TSC) is an auto-
somal dominant disorder characterized by men-
tal retardation, epilepsy and development of tu-
mors termed hamartomas such as angiofibroma
of the face and on the skin, cardiac rhabdo-
myoma, ungal fibroma, phakoma of the retina
and angiomyolipoma of the kidney (Gomez,
1988).  In the central nervous system, cortical
tubers in the cerebrum and cerebellum, peri-
ventricular nodules and giant cell astrocytoma
are characteristic lesions.  The frequency of
TSC among the general population is about 1 in
10,000 to 30,000 and it occurs in all racial
groups (Gomez, 1988; Ohno et al, 1982).  Link-
age studies have shown two loci for TSC:  one
on chromosome 9q34.3 (TSC1) and another on
chromosome 16p13.3 (TSC2) (Fryer et al.,
1987; Kandts et al., 1992; Povey et al., 1994).
Recently, the TSC2 gene has been isolated and
characterized (The European Chromosome
Tuberous Sclerosis Consortium, 1993).  The
gene for the TSC1 locus on chromosome 9q34
has not yet been identified.  Several mutations
in the TSC2 gene of TSC patients have been
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found (The European Chromosome Tuberous
Sclerosis Consortium, 1993; Kuma et al., 1995a,
1995b).
Loss of heterozygosity on chromosome
16p13.3 has been observed in the hamartomas
from TSC2 patients, suggesting the role of tu-
mor suppressor function of the TSC2 gene prod-
uct (Green et al., 1994).  The Eker rat, one type
of animal model for dominantly inherited can-
cer, which bears a gene mutation in the TSC2
gene and develops tumors in kidneys (renal car-
cinoma) and other tissues has also been found to
exhibit a loss of heterozygosity in tumors (Hino
et al., 1994; Kobayashi et al., 1995; Kubo et al.,
1995).
The TSC2 gene encodes a 1784-amino acid
protein, tuberin, which shares a region of ho-
mology with the GTPase-activating protein for
rap1 (rap1-GAP) (Wienecke et al., 1995).  It has
been predicted that this region of homology
interacts with rap1 (p21-ras-related protein)
which functions to regulate cytoskeletal inter-
actions both in mammalian platelets and in the
budding pathway of yeast cells (McCabe et al.,
1992; White et al., 1992).  The expression of
rap1-GAP especially suppresses the random
budding due to the expression of rap1, sug-
gesting that rap1-GAP may be required for non-
random selective budding in yeast cells
(McCabe et al., 1992).  Recently, it has been dem-
onstrated by Northern blot analysis and in situ
hybridization for TSC2 mRNA that the TSC2
gene is expressed at high levels in specific re-
gions of the adult and developing brain (Geist
and Gutmann, 1995).  Together with the puta-
tive function of rap1-GAP as a regulatory factor
in budding, finding on the high expression of
the TSC2 gene in the mammalian brain raises a
new question of whether or not the TSC2 gene
product tuberin has unique roles in the develop-
ment and cellular basis of synaptic plasticity of
the central nervous system which are both
closely related to cytoskeletal interactions, in
addition to the tumor suppressor function.
In this study, using the in situ hybridization
technique, we have described the neuronal pat-
tern of the TSC2 gene expression in the mouse
brain in order to examine which type of neurons
express the most abundant TSC2 gene and have
discussed the possible function of the TSC2 in
the central nervous system.
Materials and Methods
Production and subcloning of the TSC2
cDNA fragment
Total cellular RNA from a human normal skin
fibroblast cell line was purified by the acid-
guanidium thiocyanate-phenolchloroform ex-
traction method followed by the elimination of
genomic DNA using RNase-free DNase I.  The
TSC2 cDNA fragment (810 bp of human TSC2
cDNA) was generated from the total RNA by
the reverse transcription-coupled polymerase
chain reaction (RT-PCR) method using forward
primer (F: 5'-AGAAGGCTTCTCCAG-AACT-
3') and reverse primer (R: 5'-GGAGGTGGA
CCT-CGAGTGCCTT-3').  The RT-PCR prim-
ers were designed to amplify a region of 810
bases corresponding to bases 2280–3090 of the
human TSC2 sequence (The European Chromo-
some Tuberus Sclerosis Consortium, 1993).  The
TSC2 cDNA fragment thus produced was sub-
cloned into pGEM-5Zf(+) plasmid (Promega).
Northern blot analysis
Tissues:  RNA was extracted from brain
regions and other peripheral tissues of normal
C57 BL/KsJ mice (10–12 weeks old) using the
cesium chloride ultra centrifugation method.
For each sample, 45–135 µg of total RNA was
denatured by heating at 65˚C for 10 min with
50% formamide, separated electrophoretically
on a 1% denaturing formaldehyde agarose gel
and transferred to nitrocellulose (Hybond-N+,
Amersham, Bucks, United Kingdom) by North-
ern transfer.
Probes:  For all mouse tissues, the TSC2
cDNA probes used for Northern blot analysis
were the inserts from the cloned human TSC2
cDNA fragment.  The TSC2 cDNA probe and γ
actin cDNA probe were labeled with [α-
32P]CTP using the random primer reaction.
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Hybridization conditions:  The blots were
prehybridized with a buffer containing 50%
formamide, 5 × SSC, 5 × Denhardt, 50 mM
NaH2PO4, 0.5% SDS, 0.25 mg/mL denatured
salmon sperm at 42˚C for 2 h and then hybrid-
ized at 42˚C overnight in the same buffer con-
taining labeled cDNA probes (4 × 108 cpm/mL).
Blots were first washed 3 times at room temper-
ature in 2 × SSC for 15 min and then, for higher
stringency, 3 times at 62–65˚C in 0.2 × SSC, 1.0%
SDS for 30–60 min.  Finally, blots were rinsed
with 2 × SSC at room temperature for 10 min.
The blots were apposed to a Bio-rad molecular
imaging plate for 4 days to visualize the inten-
sity and localization of the probe.  To normalize
the quality of the RNA, a 32P-labeled actin cDNA
probe was used for each blot at 2 × 108 cpm/mL
with the same hybridization conditions.
In situ hybridization
Tissues:  Normal C57BL/KsJ mice (12–15
weeks old) were deeply anesthetized with sodi-
um pentobarbital and perfused transcardially
with ice-cold 20 mL heparinized saline follow-
ed by ice-cold 50 mL phosphate buffered 4%
paraformaldehyde.  The brains were removed,
postfixed in the fixative for 1 h, saturated in
30% sucrose prepared by diethyl pyrocarbonate
(DEPC) treated water overnight in the cold
(4˚C).  The brains were cut into the serial coro-
nal sections (40 µm thickness) on a freezing
microtome and free-floated in 0.1 M phosphate
buffer prepared by DEPC water.
Probes: For in situ hybridization, digox-
igenin-labeled antisense and sense riboprobes to
TSC2 mRNA were synthetized as follows:  the
digoxigenin-labeled TSC2 antisense riboprobes
were synthesized by the transcription of a hu-
man TSC2 cDNA fragment (810 bp) (amplified
by RT-PCR and inserted into the pGEM-5Zf(+)
plasmid as described above) with SP6 poly-
merase after linearization of the template DNA
by restriction enzyme SphI, while the digox-
igenin-labeled TSC2 sense riboprobes were
synthesized with T7 polymerase after linear-
ization of the template DNA by restriction en-
zyme EcoRI, using digoxigenin-labeled UTP as
substrates (RNA labeling Kit, Boehringer
Mannheim, Germany).
Hybridization conditions:  The sections
were processed by a free-floating method pre-
viously described (Saji et al., 1995).  Briefly,
the free-floating sections were prehybridized at
55˚C for 3 h in 50% formamide, 10% dextran, 2
× Denhart’s solution, 2 × SSC (1 × SSC is 0.15
M sodium chloride + 0.015 M sodium citrate),
0.5 mg/mL denatured salmon sperm DNA, 1
mg/mL yeast tRNA and 0.25% SDS.   Hybrid-
ization with digoxigenin-labeled riboprobes
was performed by adding the probes (10 ng/
mL) to the prehybridization buffer containing
the sections (50–100 µL/section) and incubat-
ing at 55˚C overnight.  The sections were wash-
ed with the incubation in 50% formamide, 2 ×
SSC at 45˚C for 20 min and in 2 × SSC at 37˚C
for 10 min, followed by RNase A treatment (20
mg/mL in 2 × SSC) at 37˚C for 30 min and by
rinsing with a dilutional series of SSC solution
at room temperature (2 × SSC twice, 1 × SSC
twice, 0.5 × SSC for 10 min each).  Then the
sections were processed for immunohistochem-
istry using anti-digoxigenin alkaline phosphatase
Fig. 1.  Expression of TSC2 mRNA in mouse
tissues.  A poly(A)+RNA Northern blot obtained
from various mouse tissues was probed with the
TSC2 cDNA probe.  The blot was reprobed with an
actin cDNA probe as a control for quantity of RNA.
Each lane indicates a blot from: 1) the liver, 2) the
brain, 3) the kidney, 4) the spleen and 5) the heart,
respectively.  There is wide spread TSC2 mRNA
expression in many tissues with high levels of
expression (4.8–3.4% of actin) in the liver, brain and
spleen and lower levels (1.2% of actin) in kidney,
when corrected for amount of RNA by expression of
actin mRNA.
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conjugate (1:500, Boehringer Mannheim).  To
visualize the hybrid molecules, the sections
were incubated in a reaction solution with X-
phosphate and nitroblue tetrazolium salt (NBT)
for 24 h and mounted on subbed slides.
Results
Expression of TSC2 gene in the various
mouse tissues analyzed by Northern blot
Northern blot analysis of poly (A)+RNA from
several mouse tissues (liver, brain, kidney,
spleen and heart) revealed that the TSC2
mRNA was widely expressed in many tissues
including the brain.  In all tissues examined,
there was one transcript evident as a 5.5 kb
RNA signal (Fig. 1).  When corrected for amount
of RNA by expression of actin mRNA as a
control, high levels of TSC2 mRNA were
expressed in the liver (4.8% of actin), brain
(3.4% of actin), spleen (4.2% of actin), with
moderate levels in the heart (2.9% of actin) and
lower levels in the kidney (1.2% of actin).
Neuron type specific expression of the
TSC2 gene in the brain demonstrated by
in situ hybridization
Figure 2 shows coronal sections of the hippo-
campus hybridized for TSC2 mRNA with anti-
sense TSC2 riboprobes or sense TSC2 ribo-
probes.  As seen in Figs. 2A and F, the section
hybridized with sense TSC2 riboprobes indicat-
ed the red colored background and neurons
which were weakly stained by non-specific
binding of labeled riboprobes.  In addition to
the red colored background staining by non-
specific binding of labeled probes shown in the
hippocampal section hybridized with sense
TSC2 probes (Fig. 2A), the hippocampal sec-
tion hybridized with antisense TSC2 probes
demonstrated neurons with a purple colored
cytoplasm in the CA1-CA4 pyramidal layers,
dentate granular layer and hilus (Figs. 2B to E)
which expressed TSC2 mRNA at a high level.
In the dendritic area or area rich in fiber tracts
like the striatum radiatum, striatum oriens and
dentate molecular layer in the hippocampus (r,
o in Figs. 2C to E, and m in Fig. 2E), there were
a few TSC2 gene expressing cells.
In the coronal sections hybridized with anti-
sense TSC2 probes, large interneurons in the
striatum (arrows in Fig. 3B), large neurons of
the Purkinje cell layer in the cerebellum (p in
Fig. 3E), neurons of the piriform cortex (Fig.
3D) and large neurons of the facial nucleus in
the medulla (f in Fig. 3F) exhibited expression
of TSC mRNA at high levels with the intensely
purple-colored cytoplasm.  On the other hand,
most neurons in the cerebral cortex (Fig. 3A),
septum (not shown), thalamus (not shown),
striatum (Fig. 3B), substantia nigra compacta (c
in Fig. 3C), and reticular formation in the medu-
lla (Fig. 3F) expressed moderate or slight levels
of TSC2 mRNA, having their cytoplasm weak-
ly stained with purple-colored TSC2 signals
(Fig. 3).  As seen in Fig. 3E, the cerebellar cor-
tex had a typical laminar distribution of TSC2
mRNA signals which consisted of a moderately
signal expressing granular layer (g in Fig. 3E), a
highly expressing Purkinje cell layer (p in Fig.
3E) and a molecular layer (m in Fig. 3E) with
the slightest expression of TSC2 signals.  Be-
sides the cerebellar molecular layer and hippo-
campal striatal areas, other reticular areas like
the substantia nigra reticulata (r in Fig. 2E) ex-
hibited only the slightest expression of TSC2
mRNA.
The degree of TSC2 gene expression in var-
ious types of neurons is summarized in Table 1.
Discussion
An essential step in unraveling the functions of
the TSC2 gene product tuberin in the mature
mammalian brain is to determine which
neuronal types show the most abundant
expression of the TSC2 gene and to establish
the common morphological features of the high
TSC2 expressing neurons.  The present study
demonstrates (i) that TSC2 signals are
expressed in the pyramidal neurons of the
hippocampal CA1-CA4, granule cells of the
dentate gyrus, neurons of the piriform cortex,
large interneurons of the striatum, Purkinje
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Fig. 2.  Distribution of TSC2 mRNA in the sections through the hippocampus by in situ hybridization with
digoxigenin-labeled sense or antisense TSC2 riboprobes.  A: Photomicrograph of the hippocampal section
hybridized with sense TSC2 riboprobes.  B: Photomicrograph of the hippocampal section hybridized with
antisense TSC2 riboprobes.  C–E: High power views of the CA1 (C), CA3 (D), CA4 (E) sector and dentate
gyrus (DG) region (E) from areas indicated by frames in B, illustrating TSC2 mRNA highly expressing
neurons with purple colored cytoplasm.  F: High power view of the CA4 sector and DG region indicated by a
frame in A, showing the red colored background stain by non-specific binding of the probes.  o, stratum
oriens; p, pyramidal layer; r, stratum radiatum; m, molecular layer; g, granule layer; h, hilus.   Scale bar = 500
µm in A and B; 100 µm in C–F.
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Fig. 3.  Distribution of TSC2 mRNA in the sections through the cerebral cortex, striatum, substantia nigra,
piriform cortex, cerebellum and medulla oblongata by in situ hybridization with digoxigenin-labeled
antisense TSC2 riboprobes.  A: High power picture of TSC2 mRNA expressing neurons in the cerebral
cortex.  B: High power picture of TSC2 mRNA expressing neurons in the striatum, which includes large
interneurons (arrows) with cytoplasm highly hybridized by TSC2 signals.  C: High power view of TSC2
signals expressing neurons in the substantia nigra.  D: Photomicrograph of TSC2 signals expressing neurons
in the coronal section of the piriform cortex.   E: Photomicrograph of the cerebellar cortex showing a typical
laminar distribution of TSC2 mRNA expressing neurons.  F: Photomicrograph of TSC2 mRNA expressing
neurons in the coronal section of the medulla oblongata at the level of the facial nucleus.  c, substantia nigra
compacta; r, substantia nigra reticulata; f, facial nucleus; g, granule cell layer; p, purkinje cell layer; m,
molecular layer.  Scale bar = 100 µm in A–C; 200 µm in D–F.
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spikes (Wong et al, 1979; Llinas and Sugimori,
1980; Ross and Werman, 1987; Tank et al.,
1988; Regehr et al 1989; Jaffe et al., 1992;
Yuste et al., 1994).  In contrast to the abundant
expression of the TSC2 gene in these large- or
medium-sized neurons, cells in the cerebellar
granule layer which were characterized by their
tiny cell size and poor dendritic structures
(Palay and Chan-Palay, 1974) expressed a
lesser amount of TSC2 signals, despite having
the highest cell density in the layer.  Also, small
non-neural cells like oligodendrocytes or astro-
cytes which exist abundantly in the striatal
regions rich in dendrites and fiber tracts appear-
ed not to be stained by TSC2 mRNA signals, as
seen in the radiatum, oriens and molecular layer
of the hippocampus (Fig. 2).
Current studies on the molecular and cell-
ular basis for memory and learning have accu-
mulated evidence that the hippocampal pyrami-
dal neurons, dentate granule cells, cortical
pyramidal neurons and cerebellar purkinje cells
showed a long-term potentiation (LTP) (Bliss
and Lomo, 1973; Artola and Singer, 1987; Brown
et al., 1988; Bashir et al., 1991; Madison et al.,
1991; Bliss and Collingridge, 1993) or long-term
depression (LTD) (Ito et al., 1982; Kano and
Kato, 1987; Ito, 1989) thought of as activity-
dependent long-term changes in synaptic effi-
cacy.  On the other hand, the morphological
cells of the cerebellum and motor
neurons in the medulla at high levels,
and (ii) that the intermediate levels of
TSC2 signals are expressed in most
neurons of the cerebral cortex, septum,
striatum, reticular formation in the
medulla and substantia nigra compacta.
In the brains from individuals
affected with TSC, cortical tubers,
periventricular nodules and giant cell
astrocytoma are the characteristic
les ions  (Gomez,  1988) .   These
hamartomas in the central nervous
system are considered to be due to errors
in differentiation and migration of
germinal cells (Nishimura et al., 1985),
which result from loss of heterozygosity
for the TSC2 gene observed in the
abnormal tissues.  Because of the
heterozygosity of TSC2 DNA markers on
chromosome 16p13.3 in most affected cells, a
lesser amount of TSC2 products must be
observed in normal tissues of the brain from
TSC patients.  However, neurons in the normal
tissues from TSC patients do not exhibit any
other degenerative features, even with the
reduced amount of TSC gene products.  To-
gether with this lack of degenerative features of
neurons in the brain from TSC patients, from
the present finding on the high levels of TSC2
gene expression in the specific types of neurons
in the normal brain, the possibility emerges that
the function of TSC2 gene products in mature
neurons may be quite other than proliferation,
differentiation or a tumor suppressor function.
The most abundant expression of the TSC2
gene was exhibited specifically in large- or
medium-sized neurons of the hippocampal
pyramidal layer, dentate granular layer, piri-
form cortex, striatum, cerebellar purkinje cell
layer and medullary motor nucleus, which  all
had the common feature of well-developed
dendritic trees  (McGeer et al., 1978).  Especial-
ly, as novel imaging and electrophysiological
techniques have revealed, these cerebellar
Purkinje neurons, cortical pyramidal and hippo-
campal pyramidal neurons have active den-
drites of which entire trees are covered with
calcium channels and demonstrate calcium
Table 1.  Degree of TSC2 gene expression in vari-
ous types of neurons
 Brain region           Neuron type                TSC2 gene
   expression
Cerebral cortex Most neurons ++
Septum Most neurons +
Piriform cortex Most neurons +++
Striatum Medium neurons ++
Large interneurons +++
Hippocampus Pyramidal cells +++
Dentate granule cells +++
Helus neurons +++
Substantia nigra Neurons of the pars compacta +
Cerebellum Purkinje cells +++
Granule cells +
Medulla Neurons of reticular formation +
Neurons of the facial nucleus +++
Degree of expression:  +++,  high; ++, moderate; +, slight.
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basis for memory and learning was considered
to lie in modifications of synaptic connec-
tivities, especially in the activity-dependent
changes of the dendritic spines as a result of
intracellular molecular alterations in response
to repeated stimulation (Guthrie et al., 1991;
Muller and Connor, 1991; Lisman and Harris,
1993; Shepherd, 1994).  It has been reported
that the TSC2 gene product shares a region of
homology with the GTPase-activating protein
for rap1 which is predicted to interact with rap1
(Wienecke et al., 1995).  This relation of the
TSC2 gene product with rap1, which functions
in the regulation of cytoskeletal interaction in
mammalian platelets and in the budding of
yeast cells (McCabe et al., 1992; White et al.,
1992), strongly supports the notion that the
TSC2 gene product may function in the forma-
tion of the dendritic spines, thus conferring
synaptic plasticity to neurons.  Since neurons
showing the highest TSC2 expression were of
the cell types which were deeply involved in
long-term memories and were rich in synaptic
plasticity, it is likely that TSC2 gene products
play a role in building and maintaining the
higher functions of neuron networks for mem-
ory and learning.
Therefore, the possible function of the TSC2
gene product in the formation of dendritic spines
and the use-dependent modification of synaptic
connectivities may be relevant to mental retar-
dation observed in TSC patients.
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